Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines

European Journal of Pharmaceutical Sciences

Volumn 26, Issue 3-4, 2005, Pages 266-279

  Korjamo, Timo ^a   Honkakoski, Paavo ^a   Toppinen, Marjo Riitta ^a   Niva, Sanna ^a   Reinisalo, Mika ^a   Palmgrén, Joni J ^a   Mönkkönen, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Caco 2; CAR; P glycoprotein; Permeability; PXR

Indexed keywords

ATENOLOL; BACLOFEN; CALCEIN; CALCITRIOL; CEFALEXIN; CYCLOSPORIN A; CYTOCHROME P450 2D; CYTOCHROME P450 3A4; GLYCOPROTEIN P; IBUPROFEN; MULTIDRUG RESISTANCE PROTEIN 1; PHENAZONE; PREGNANE X RECEPTOR; PROGESTERONE; PROPRANOLOL; RHODAMINE 123; VERAPAMIL; VINCRISTINE SULFATE;

ABSORPTION; ARTICLE; CELL LINE; CELL STRAIN CACO 2; CONTROLLED STUDY; CULTURE MEDIUM; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PERMEABILITY; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; XENOBIOTIC METABOLISM;

CACO-2 CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; FLUORESCEINS; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; P-GLYCOPROTEIN; PERMEABILITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 24644443825     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2005.06.004     Document Type: Article

References (69)

1. S.V. Ambudkar, S. Dey, C.A. Hrycyna, M. Ramachandra, I. Pastan, and M.M. Gottesman Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu. Rev. Pharmacol. Toxicol. 39 1999 361 398
2. A. Aranda, and A. Pascual Nuclear hormone receptors and gene expression Physiol. Rev. 81 2001 1269 1304
3. P. Artursson, K. Palm, and K. Luthman Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv. Drug Deliv. Rev. 46 2001 27 43
4. C.A. Bergstrom, M. Strafford, L. Lazorova, A. Avdeef, K. Luthman, and P. Artursson Absorption classification of oral drugs based on molecular surface properties J. Med. Chem. 46 2003 558 570
5. T. Cercos-Fortea, A. Polache, A. Nacher, E. Cejudo-Ferragud, V.G. Casabo, and M. Merino Influence of leucine on intestinal baclofen absorption as a model compound of neutral alpha-aminoacids Biopharm. Drug Dispos. 16 1995 563 577
6. L.M. Chan, S. Lowes, and B.H. Hirst The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability Eur. J. Pharm. Sci. 21 2004 25 51
7. Z.S. Chen, T. Kawabe, M. Ono, S. Aoki, T. Sumizawa, T. Furukawa, T. Uchiumi, M. Wada, M. Kuwano, and S.I. Akiyama Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter Mol. Pharmacol. 56 1999 1219 1228
8. S. Chong, S.A. Dando, K.M. Soucek, and R.A. Morrison In vitro permeability through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system Pharm. Res. 13 1996 120 123
9. C.L. Crespi, B.W. Penman, and M. Hu Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4 Pharm. Res. 13 1996 1635 1641
10. C.L. Cummins, W. Jacobsen, U. Christians, and L.Z. Benet CYP3A4-transfected Caco-2 cells as a tool for understanding biochemical absorption barriers: studies with sirolimus and midazolam J. Pharmacol. Exp. Ther. 308 2004 143 155
11. S. Döppenschmitt, P. Langguth, C.G. Regardh, T.B. Andersson, C. Hilgendorf, and H. Spahn-Langguth Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay J. Pharmacol. Exp. Ther. 288 1999 348 357
12. S. Döppenschmitt, H. Spahn-Langguth, C.G. Regardh, and P. Langguth Role of P-glycoprotein-mediated secretion in absorptive drug permeability: an approach using passive membrane permeability and affinity to P-glycoprotein J. Pharm. Sci. 88 1999 1067 1072
13. L. Drocourt, J.C. Ourlin, J.M. Pascussi, P. Maurel, and M.J. Vilarem Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the Vitamin D receptor pathway in primary human hepatocytes J. Biol. Chem. 277 2002 25125 25132
14. M. Duvvuri, Y. Gong, D. Chatterji, and J.P. Krise Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60 J. Biol. Chem. 279 2004 32367 32372
15. A. Eneroth, E. Astrom, J. Hoogstraate, D. Schrenk, S. Conrad, H.M. Kauffmann, and K. Gjellan Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction Eur. J. Pharm. Sci. 12 2001 205 214
16. H.A. Engman, H. Lennernas, J. Taipalensuu, C. Otter, B. Leidvik, and P. Artursson CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies J. Pharm. Sci. 90 2001 1736 1751
17. M. Essodaigui, H.J. Broxterman, and A. Garnier-Suillerot Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein Biochemistry 37 1998 2243 2250
18. J.M. Fisher, S.A. Wrighton, P.B. Watkins, P. Schmiedlin-Ren, J.C. Calamia, D.D. Shen, K.L. Kunze, and K.E. Thummel First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayers J. Pharmacol. Exp. Ther. 289 1999 1134 1142
19. M.E. Ganapathy, M. Brandsch, P.D. Prasad, V. Ganapathy, and F.H. Leibach Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2 J. Biol. Chem. 270 1995 25672 25677
20. M. Garrigos, L.M. Mir, and S. Orlowski Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase - further experimental evidence for a multisite model Eur. J. Biochem. 244 1997 664 673
21. A.G. Halline, N.O. Davidson, S.F. Skarosi, M.D. Sitrin, C. Tietze, D.H. Alpers, and T.A. Brasitus Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells Endocrinology 134 1994 1710 1717
22. P. Honkakoski Nuclear receptors CAR and PXR in metabolism and elimination of drugs Curr. Pharmacogenom. 2003 75 85
23. P. Honkakoski, I. Jääskelainen, M. Kortelahti, and A. Urtti A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR) Pharm. Res. 18 2001 146 150
24. J. Hoskins, S.V. DeHerdt, R.E. Moore, and T.F. Bumol The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1 Int. J. Cancer 53 1993 680 688
25. M. Hu, J. Chen, L. Zheng, A.H. Dantzig, and R.E. Stratford Jr. Uptake characteristics of loracarbef and cephalexin in the Caco-2 cell culture model: effects of the proton gradient and possible presence of a distinctive second component J. Pharm. Sci. 85 1996 767 772
26. J. Karlsson, and P. Artursson A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers Int. J. Pharm. 71 1991 55 64
27. T. Kawamoto, T. Sueyoshi, I. Zelko, R. Moore, K. Washburn, and M. Negishi Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene Mol. Cell. Biol. 19 1999 6318 6322
28. L. Laitinen, H. Kangas, A.M. Kaukonen, K. Hakala, T. Kotiaho, R. Kostiainen, and J. Hirvonen N-in-one permeability studies of heterogeneous sets of compounds across Caco-2 cell monolayers Pharm. Res. 20 2003 187 197
29. J.M. Lehmann, D.D. McKee, M.A. Watson, T.M. Willson, J.T. Moore, and S.A. Kliewer The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions J. Clin. Invest. 102 1998 1016 1023
30. K.A. Lentz, J. Hayashi, L.J. Lucisano, and J.E. Polli Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system Int. J. Pharm. 200 2000 41 51
31. J.M. Maglich, C.M. Stoltz, B. Goodwin, D. Hawkins-Brown, J.T. Moore, and S.A. Kliewer Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification Mol. Pharmacol. 62 2002 638 646
32. J. Mäkinen, C. Frank, J. Jyrkkärinne, J. Gynther, C. Carlberg, and P. Honkakoski Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors Mol. Pharmacol. 62 2002 366 378
33. H. Matsumoto, R.H. Erickson, J.R. Gum, M. Yoshioka, E. Gum, and Y.S. Kim Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2 Gastroenterology 98 1990 1199 1207
34. L.B. Moore, J.M. Maglich, D.D. McKee, B. Wisely, T.M. Willson, S.A. Kliewer, M.H. Lambert, and J.T. Moore Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors Mol. Endocrinol. 16 2002 977 986
35. T. Nakamura, T. Sakaeda, N. Ohmoto, Y. Moriya, C. Komoto, T. Shirakawa, A. Gotoh, M. Matsuo, and K. Okmura Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines Pharm. Res. 20 2003 324 327
36. T. Nakamura, T. Sakaeda, N. Ohmoto, T. Tamura, N. Aoyama, T. Shirakawa, T. Kamigaki, T. Nakamura, K.I. Kim, S.R. Kim, Y. Kuroda, M. Matsuo, M. Kasuga, and K. Okumura Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas Drug Metab. Dispos. 30 2002 4 6
37. H.R. Neave, and P.L. Worthington Distribution-Free Tests 1988 Unwin Hyman Ltd. London
38. S. Neuhoff, A.L. Ungell, I. Zamora, and P. Artursson pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions Pharm. Res. 20 2003 1141 1148
39. J.J. Palmgrén, J. Mönkkonen, E. Jukkola, S. Niva, and S. Auriola Characterization of Caco-2 cell monolayer drug transport properties by cassette dosing using UV/fluorescence HPLC Eur. J. Pharm. Biopharm. 57 2004 319 328
40. E.C. Paul, J. Hochman, and A. Quaroni Conditionally immortalized intestinal epithelial cells: novel approach for study of differentiated enterocytes Am. J. Physiol. 265 1993 C266 C278
41. A. Pfrunder, H. Gutmann, C. Beglinger, and J. Drewe Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines J. Pharm. Pharmacol. 55 2003 59 66
42. M. Pinto, S. Robine-Leon, M.C. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh, and A. Zweibaum Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture Biol. Cell. 47 1983 323 330
43. J.W. Polli, S.A. Wring, J.E. Humphreys, L. Huang, J.B. Morgan, L.O. Webster, and C.S. Serabjit-Singh Rational use of in vitro P-glycoprotein assays in drug discovery J. Pharmacol. Exp. Ther. 299 2001 620 628
44. Prime-Chapman, H.M., Fearn, R.A., Cooper, A.E., Moore, V., Hirst, B.H., 2004. Differential MRP1-6 isoform expression and function in human intestinal epithelial Caco-2 cells. J. Pharmacol. Exp. Ther.
45. T. Prueksaritanont, L.M. Gorham, J.H. Hochman, L.O. Tran, and K.P. Vyas Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells Drug Metab. Dispos. 24 1996 634 642
46. W.S. Putnam, L. Pan, K. Tsutsui, L. Takahashi, and L.Z. Benet Comparison of bidirectional cephalexin transport across MDCK and caco-2 cell monolayers: interactions with peptide transporters Pharm. Res. 19 2002 27 33
47. W.S. Putnam, S. Ramanathan, L. Pan, L.H. Takahashi, and L.Z. Benet Functional characterization of monocarboxylic acid, large neutral amino acid, bile acid and peptide transporters, and P-glycoprotein in MDCK and Caco-2 cells J. Pharm. Sci. 91 2002 2622 2635
48. J.M. Rosenfeld, R. Vargas Jr., W. Xie, and R.M. Evans Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor Mol. Endocrinol. 17 2003 1268 1282
49. A.H. Schinkel, S. Kemp, M. Dolle, G. Rudenko, and E. Wagenaar N-Glycosylation and deletion mutants of the human MDR1 P-glycoprotein J. Biol. Chem. 268 1993 7474 7481
50. P. Schmiedlin-Ren, K.E. Thummel, J.M. Fisher, M.F. Paine, K.S. Lown, and P.B. Watkins Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3 Mol. Pharmacol. 51 1997 741 754
51. P. Schmiedlin-Ren, K.E. Thummel, J.M. Fisher, M.F. Paine, and P.B. Watkins Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor Drug Metab. Dispos. 29 2001 1446 1453
52. T. Sueyoshi, T. Kawamoto, I. Zelko, P. Honkakoski, and M. Negishi The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene J. Biol. Chem. 274 1999 6043 6046
53. D. Sun, H. Lennernas, L.S. Welage, J.L. Barnett, C.P. Landowski, D. Foster, D. Fleisher, K.D. Lee, and G.L. Amidon Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs Pharm. Res. 19 2002 1400 1416
54. H. Suzuki, and Y. Sugiyama Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine Eur. J. Pharm. Sci. 12 2000 3 12
55. T.W. Synold, I. Dussault, and B.M. Forman The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux Nat. Med. 7 2001 584 590
56. J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers J. Pharmacol. Exp. Ther. 299 2001 164 170
57. I. Tamai, H. Takanaga, H. Maeda, Y. Sai, T. Ogihara, H. Higashida, and A. Tsuji Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids Biochem. Biophys. Res. Commun. 214 1995 482 489
58. M.D. Troutman, and D.R. Thakker Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells Pharm. Res. 20 2003 1192 1199
59. A. Tsuji, H. Takanaga, I. Tamai, and T. Terasaki Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism Pharm. Res. 11 1994 30 37
60. A. Tsuji, and I. Tamai Carrier-mediated intestinal transport of drugs Pharm. Res. 13 1996 963 977
61. P.H. Vachon, N. Perreault, P. Magny, and J.F. Beaulieu Uncoordinated, transient mosaic patterns of intestinal hydrolase expression in differentiating human enterocytes J. Cell. Physiol. 166 1996 198 207
62. I.C. van der Sandt, M.C. Blom-Roosemalen, A.G. de Boer, and D.D. Breimer Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines Eur. J. Pharm. Sci. 11 2000 207 214
63. E.J. Wang, C.N. Casciano, R.P. Clement, and W.W. Johnson Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors Biochem. Biophys. Res. Commun. 289 2001 580 585
64. L. Xu, C.K. Glass, and M.G. Rosenfeld Coactivator and corepressor complexes in nuclear receptor function Curr. Opin. Genet. Dev. 9 1999 140 147
65. S. Yamashita, T. Furubayashi, M. Kataoka, T. Sakane, H. Sezaki, and H. Tokuda Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells Eur. J. Pharm. Sci. 10 2000 195 204
66. S. Yamashita, K. Konishi, Y. Yamazaki, Y. Taki, T. Sakane, H. Sezaki, and Y. Furuyama New and better protocols for a short-term Caco-2 cell culture system J. Pharm. Sci. 91 2002 669 679
67. J.J. Yang, K.J. Kim, and V.H. Lee Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers Pharm. Res. 17 2000 533 538
68. S. Yee In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth Pharm. Res. 14 1997 763 766
69. H. Yu, T.J. Cook, and P.J. Sinko Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages Pharm. Res. 14 1997 757 762